BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16024627)

  • 1. Enforced expression of superoxide dismutase 2/manganese superoxide dismutase disrupts autocrine interleukin-6 stimulation in human multiple myeloma cells and enhances dexamethasone-induced apoptosis.
    Hodge DR; Xiao W; Peng B; Cherry JC; Munroe DJ; Farrar WL
    Cancer Res; 2005 Jul; 65(14):6255-63. PubMed ID: 16024627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the promoter reveal a cause for the reduced expression of the human manganese superoxide dismutase gene in cancer cells.
    Xu Y; Krishnan A; Wan XS; Majima H; Yeh CC; Ludewig G; Kasarskis EJ; St Clair DK
    Oncogene; 1999 Jan; 18(1):93-102. PubMed ID: 9926924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of autocrine IL-6 expression in multiple myeloma cells.
    Gerlo S; Haegeman G; Vanden Berghe W
    Cell Signal; 2008 Aug; 20(8):1489-96. PubMed ID: 18502099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
    Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
    Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manganese superoxide dismutase deficiency enhances cell turnover via tumor promoter-induced alterations in AP-1 and p53-mediated pathways in a skin cancer model.
    Zhao Y; Oberley TD; Chaiswing L; Lin SM; Epstein CJ; Huang TT; St Clair D
    Oncogene; 2002 May; 21(24):3836-46. PubMed ID: 12032821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproliferative and antiapoptotic effects of crel may occur within the same cells via the up-regulation of manganese superoxide dismutase.
    Bernard D; Quatannens B; Begue A; Vandenbunder B; Abbadie C
    Cancer Res; 2001 Mar; 61(6):2656-64. PubMed ID: 11289144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulated manganese superoxide dismutase expression and resistance to oxidative injury in p53-deficient cells.
    Pani G; Bedogni B; Anzevino R; Colavitti R; Palazzotti B; Borrello S; Galeotti T
    Cancer Res; 2000 Aug; 60(16):4654-60. PubMed ID: 10969820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of protein phosphatase 1 and 2A in an IL-6-mediated autocrine growth loop of human myeloma cells.
    Kang HS; Lee BS; Yang Y; Park CW; Ha HJ; Pyun KH; Choi I
    Cell Immunol; 1996 Mar; 168(2):174-83. PubMed ID: 8640863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of manganese superoxide dismutase on growth and invasive properties of human estrogen-independent breast cancer cells.
    Kattan Z; Minig V; Leroy P; Dauça M; Becuwe P
    Breast Cancer Res Treat; 2008 Mar; 108(2):203-15. PubMed ID: 17473980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of sphingosine kinase mediates suppressive effect of interleukin-6 on human multiple myeloma cell apoptosis.
    Li QF; Wu CT; Duan HF; Sun HY; Wang H; Lu ZZ; Zhang QW; Liu HJ; Wang LS
    Br J Haematol; 2007 Sep; 138(5):632-9. PubMed ID: 17686057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of superoxide dismutase and cytotoxicity by manganese in human breast cancer cells.
    Thongphasuk J; Oberley LW; Oberley TD
    Arch Biochem Biophys; 1999 May; 365(2):317-27. PubMed ID: 10328827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factors.
    Jourdan M; Mahtouk K; Veyrune JL; Couderc G; Fiol G; Redal N; Duperray C; De Vos J; Klein B
    Eur Cytokine Netw; 2005; 16(1):57-64. PubMed ID: 15809207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy.
    Zhang Y; Gu J; Zhao L; He L; Qian W; Wang J; Wang Y; Qian Q; Qian C; Wu J; Liu XY
    Cancer Res; 2006 Apr; 66(8):4291-8. PubMed ID: 16618754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the AKT kinase in expansion of multiple myeloma clones: effects on cytokine-dependent proliferative and survival responses.
    Hsu JH; Shi Y; Hu L; Fisher M; Franke TF; Lichtenstein A
    Oncogene; 2002 Feb; 21(9):1391-400. PubMed ID: 11857082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis.
    Chen H; Li M; Campbell RA; Burkhardt K; Zhu D; Li SG; Lee HJ; Wang C; Zeng Z; Gordon MS; Bonavida B; Berenson JR
    Oncogene; 2006 Oct; 25(49):6520-7. PubMed ID: 16702955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manganese superoxide dismutase overexpression changes plating efficiency bidirectionally according to change in redox for SaOS2 human osteosarcoma cell line.
    Komatsu M; Kuroda M; Wang Y; St Clair D; Urano M; Akaki S; Asaumi J; Kawasaki S; Hiraki Y; Kanazawa S
    Int J Oncol; 2005 Apr; 26(4):853-62. PubMed ID: 15753978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-alpha is a survival factor for human myeloma cells and reduces dexamethasone-induced apoptosis.
    Ferlin-Bezombes M; Jourdan M; Liautard J; Brochier J; Rossi JF; Klein B
    J Immunol; 1998 Sep; 161(6):2692-9. PubMed ID: 9743325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p44/42 MAP kinase-dependent regulation of catalase by autocrine human growth hormone protects human mammary carcinoma cells from oxidative stress-induced apoptosis.
    Zhu Z; Mukhina S; Zhu T; Mertani HC; Lee KO; Lobie PE
    Oncogene; 2005 May; 24(23):3774-85. PubMed ID: 15782123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PC cell-derived growth factor confers resistance to dexamethasone and promotes tumorigenesis in human multiple myeloma.
    Wang W; Hayashi J; Serrero G
    Clin Cancer Res; 2006 Jan; 12(1):49-56. PubMed ID: 16397023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of IL-6-dependent growth of myeloma cells by an acidic peptide repressing the gp130-mediated activation of Src family kinases.
    Hausherr A; Tavares R; Schäffer M; Obermeier A; Miksch C; Mitina O; Ellwart J; Hallek M; Krause G
    Oncogene; 2007 Jul; 26(34):4987-98. PubMed ID: 17310994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.